Delivery Order SPE2DB24D1205-SPE2DB25FCSYE

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $26,253.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Verzenio 150 mg tablets, a pharmaceutical product used in the treatment of various medical conditions. This award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,403.13 firm-fixed-price delivery order is for the supply of VERZENIO 150 MG TABLET in quantities of 14s. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, with a ceiling value of $23,365.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order (DO) for the supply of VERZENIO 150 MG TABLET medication, with an ultimate completion date of January 8, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,774.33, is for the delivery of VERZENIO 150 MG TABLET in support of military healthcare programs. This contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $43,968.01 in Firm Fixed Price funding for the delivery of VERZENIO 150 MG TABLET. The contract, with a completion date of November 1, 2024, was awarded on October 31, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The award is not designated under any set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $33,937.25 delivery order is for the supply of VERZENIO 100 MG TABLET UU 14S, a prescription medication. This award is a firm fixed-price contract with a completion date of July 30, 2024. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery...
This federal contract award, valued at $47,334.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The contract covers the delivery of Verzenio 100 mg tablets, a brand-name prescription medication. As the award does not indicate any set-aside...
The federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,850.45 firm fixed-price delivery order is for the supply of Verzenio 150 mg tablets, with a completion date of December 23, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $36,058.10 firm fixed-price delivery order is for the supply of VERZENIO 150 MG TABLET products. The contract has a completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This federal contract award, valued at $14,490.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VERZENIO 100 MG TABLET UU 14S, a pharmaceutical product. It is a Firm Fixed Price contract with a completion date of January 9, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCSYE
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,344.34, is for the delivery of VERZENIO 150 MG TABLET pharmaceutical products.

The contract is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/11/25, 11:25 AM